Abrams, D.I., Jay, C.A., Shade, S.B., Vizoso, H., Reda, H., Press, S., Kelly, M.E., Rowbotham, M.C., & Petersen, K.L. (2007). Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology, 68, 515-521. Retrieved from http://www.cmcr.ucsd.edu/images/PDFs/Abrams_2007.pdf

Amtmann, D., Weydt, P., Johnson K.L., Jensen, M.P., & Carter, G.T. (2004). Survey of cannabis use in patients with amyotrophic lateral sclerosis. American Journal of Hospice and Palliative Medicine, 21(2), 95-104. Retrieved from http://ajh.sagepub.com/content/21/2/95.full.pdf+html

Carter, G.T., Abood, M.E., Aggarwal, S.K., & Weiss, M.D. (2010). Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and practical applications, and a call for clinical trials. American Journal of Hospice & Palliative Medicine, 27(5), 347-356. Retrieved from http://ajh.sagepub.com/content/27/5/347.full.pdf+html

Carter, G.T., Flanagan, A.M., Earleywine, M., Abrams, D.I., Aggarwal, S.K., & Grinspoon, L. (2011). Cannabis in palliative medicine: Improving care and reducing opioid-related morbidity. American Journal of Hospice and Palliative Medicine, 28(5), 297-303. Retrieved from http://ajh.sagepub.com/content/28/5/297.full.pdf+html

Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T.D., Bentley, H., & Gouaux, B. (2012). Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ, 184(10), 1143-1150. Retrieved from http://www.cmaj.ca/content/184/10/1143.full.pdf+html

Degenhardt, L., & Hall, W.D. (2008). Commentary: The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ, 178(13), 1685-1686. Retrieved from http://www.ecmaj.ca/content/178/13/1685.full.pdf+html

Ellis, R.J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., Bentley, H., & Atkinson, J.H. (2009). Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial. Neuropsychopharmacology, 34(3), 672-680. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066045/pdf/nihms277052.pdf

Grotenhermen, F., & Muller-Vahl, K. (2012). The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int, 109(29-30), 495-501. Retrieved from http://www.aerzteblatt.de/pdf/DI/109/29/m495.pdf

Guzman, M., Duarte, M.J., Blazquez, C., Ravina, J., Rosa, M.C., Galve-Roperh, I., Sanchez, C., Velasco, G., & Gonzalez-Feria, L. (2006). A pilot clinical study of Δ 9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. British Journal of Cancer, 95, 197-203. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360617/pdf/95-6603236a.pdf

Haney, M., Gunderson, E., Rabkin, J., Hart, C.L., Vosburg, S., Comer, S., & Foltin, R. (2007). Dronabinol and marijuana in HIV-positive marijuana smokers: Caloric intake, mood and sleep. JAIDS, 45(5), 545-554. Retrieved from http://journals.lww.com/jaids/Fulltext/2007/08150/Dronabinol_and_Marijuana_in_HIV_Positive_M arijuana.9.aspx?desktopMode=true

Hazekamp, A., & Grotenhermen, F. (2010). Review on clinical studies with cannabis and cannabinoids 2005-2009. Cannabinoids, 5(special issue), 1-21. Retrieved from http://www.cannabismed.org/data/pdf/en_2010_01_special.pdf

Johnson, J.R., Burnell-Nugent, M., Lossignol. D., Ganae-Motan, E.D., Potts, R., & Fallon, M.T. (2010). Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety and tolerability of THC:CBD extract and THC extract in patients with intractable cancerrelated pain. Journal of Pain and Symptom Management, 39(2), 167-179. Retrieved from http://download.journals.elsevierhealth.com/pdfs/journals/0885-3924/PIIS0885392409007878.pdf

Lueng, L. (2011). Cannabis and its derivatives: Review of medical use. JABFM, 24(4), 452-462. Retrieved from http://www.jabfm.org/content/24/4/452.full.pdf+html

Merritt, J.C. (1982). Glaucoma, hypertension, and marijuana. Journal of the National Medical Association, 74(8), 715-716. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2552967/

National Cancer Institute. (2013, January 17 (last modified)). PDQ® Cannabis and Cannabinoids. National Cancer Institute: Bethesda, MD. Retrieved from http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional Accessed January 31, 2013.

Pletcher, M.J.,Vittinghoff, E., Kalhan, R., Richman, J., Safford, M., Sidney, S., Lin, F., & Kerstesz, S. (2012). Association between marijuana exposure and pulmonary function over 20 years. JAMA, 307(2), 173-181. Retrieved from http://jama.jamanetwork.com/article.aspx?articleid=1104848

Strasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., Ko, Y.-D., Schnelle, M., Reif, M., & Cerny, T. (2006). Comparison of orally administered cannabis extract and delta- 9tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase II, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-study-Group. Journal of Clinical Oncology, 24(21), 3394-3400. Retrieved from http://jco.ascopubs.org/content/24/21/3394.full.pdf+html

Tomida, I., Pertwee, R.G., & Azuara-Blanco, A. (2004). Cannabinoids and glaucoma. Br J Ophthalmol, 88, 708-713. Retrieved from http://bjo.bmj.com/content/88/5/708.full.pdf+html

Wang, T., Collet, J.-P., Shapiro, S., & Ware, M.A. (2008). Adverse effects of medical cannabinoids: A systematic review. CMAJ, 178(13), 1669-1678. Retrieved from http://www.cmaj.ca/content/178/13/1669.full.pdf+html

Zajicek, J., Sanders, H.P., Wright, D.E., Vickery, P.J., Ingram, W.M., Reilly, S.M., Nunn, A.J., Teare, L.J., Fox, P.J., & Thompson, A.J. (2005). Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry, 76, 1664-1669. Retrieved from http://jnnp.bmj.com/content/76/12/1664.full.pdf+html